In the modern life sciences industry, certain Japanese companies are demonstrating that it is possible to combine scientific innovation, a deep respect for nature and social responsibility. Daiwa Pharmaceutical embodies this unique approach through its commitment to the United Nations Sustainable Development Goals.
Daiwa Pharmaceutical embodies this philosophy in every aspect of its production. Rice bran, for example – the outer layers of the grain – contains valuable nutrients. Through innovative enzymatic processes using shiitake mushrooms, it is possible to extract the arabinoxylan MGN-3. This approach transforms what was previously under-utilised into a valuable ingredient, demonstrating that, with science and innovation, it is possible to use 100% of natural resources in a respectful manner.
A concrete commitment to the Sustainable Development Goals
Daiwa Pharmaceutical has committed to the United Nations’ 17 Sustainable Development Goals to build a better future by 2030. Unlike many companies that make such commitments without taking concrete action, Daiwa demonstrates its commitment through measurable initiatives.
Clean and sustainable energy (SDG 7)
The production facilities in Tsukuba run on solar power, significantly reducing greenhouse gas emissions. The adoption of renewable energy sources in industrial production represents a concrete commitment to environmental protection.
Innovation in sustainable agriculture (SDG 2)
The development of innovative lactic acid bacteria for animal feed offers alternatives to antibiotics in livestock farming. This approach contributes to healthier and more sustainable food production, reducing reliance on conventional antibiotic treatments.
Food quality and safety (SDG 12)
FSSC 22000 certification represents the highest international standard for food safety. This certification guarantees that every stage of production is monitored with the utmost rigour, from the selection of raw materials right through to the final product.
Diversity and Inclusion (SDGs 5 and 10)
Daiwa Pharmaceutical has 37.5% women in management roles and actively employs international staff. This inclusive approach has been recognised by the Japanese Ministry of Economy, which has named the company among the “300 Exemplary SMEs” for its inclusive practices.
Research and international partnerships (SDG 17)
Collaboration with international research institutions enables the sharing of knowledge and contributes to the advancement of global nutritional science. These partnerships foster innovation and the transfer of expertise between different scientific cultures.